Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Pacira Pharmaceuticals, Inc. (PCRX)    
$115.99 0.88 (0.76%) as of 4:30 Thu 2/26


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 36,055,000 as of 9/30
Market Cap: 4.18(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $62.95 - $118.04
Level I Sector: Health Care
Level II Sector:   Drugs
Level III Sector:      Drug Manufacturers - Major

Member Indexes:

      

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
 

Company Profile   Pacira Pharmaceuticals is a holding company. Through its subsidiaries, Co. is engaged in the development, commercialization and manufacture of pharmaceutical products, based on its DepoFoam drug delivery technology. Co.'s main product, EXPAREL, is marketed for the indication of postsurgical analgesia by infiltration, and is also in Phase 2 clinical trial for postsurgical analgesia-nerve block. Co.'s other products include: bupivacaine liposome injectable suspension for veterinary postsurgical analgesia; and DepoCyt(e), which is a sustained-release liposomal formulation of the chemotherapeutic agent cytarabine utilizing DepoFoam technology for the treatment of lymphomatous meningitis.

 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 2,645 3,725 3,725 5,578
Total Buy Value $250,058 $346,889 $346,889 $408,892
Total People Bought 1 3 3 4
Total Buy Transactions 1 3 3 5
Total Shares Sold 33,500 67,000 823,294 8,161,514
Total Sell Value $3,459,673 $6,593,308 $73,183,870 $280,093,544
Total People Sold 4 4 7 16
Total Sell Transactions 4 8 40 138
End Date 2014-11-30 2014-08-29 2014-02-28 2013-02-28

   
Records found: 266
  Page 1 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Scibetta James S SVP, Chief Financial Officer   •       –      –    2015-02-06 4 OE $1.61 $24,150 D/D 15,000 20,230     -
   Scibetta James S SVP, Chief Financial Officer   •       –      –    2015-02-06 4 AS $110.17 $1,668,374 D/D (15,000) 5,230 3%     
   Stack David M President, CEO and Chairman   •       •      –    2015-01-15 4 AS $97.30 $1,462,829 D/D (15,000) 1,267 23%     
   Stack David M President, CEO and Chairman   •       •      –    2015-01-15 4 OE $1.61 $24,150 D/D 15,000 16,267     -
   Hastings Paul J Director   –       •      –    2015-01-12 4 OE $13.98 $34,950 D/D 2,500 3,353     -
   Hastings Paul J Director   –       •      –    2015-01-12 4 AS $94.06 $235,150 D/D (2,500) 853 21%     
   Longenecker John P Phd Director   –       •      –    2014-12-29 4 AS $93.32 $93,320 D/D (1,000) 0 23%     
   Longenecker John P Phd Director   –       •      –    2014-12-29 4 OE $29.90 $29,900 D/D 1,000 1,000     -
   Winger Dennis L Director   –       •      –    2014-12-05 4 B $94.54 $250,058 D/D 2,645 2,645 2.39 24%     
   Scibetta James S SVP, Chief Financial Officer   •       –      –    2014-11-07 4 OE $1.61 $24,150 D/D 15,000 20,000     -
   Scibetta James S SVP, Chief Financial Officer   •       –      –    2014-11-07 4 AS $86.13 $1,307,642 D/D (15,000) 5,000 29%     
   Markvicka Taunia SVP, Chief Commercial Officer   •       –      –    2014-11-07 4 B $86.62 $19,923 I/I 230 230 1.99 29%     
   Kronenfeld Mark A. Director   –       •      –    2014-11-03 4 B $90.48 $76,908 D/D 850 1,850 2.39 25%     
   Stack David M President, CEO and Chairman   •       •      –    2014-10-15 4 AS $96.60 $1,492,418 D/D (15,000) 1,208 13%     
   Stack David M President, CEO and Chairman   •       •      –    2014-10-15 4 OE $1.61 $24,150 D/D 15,000 16,208     -
   Hastings Paul J Director   –       •      –    2014-10-10 4 AS $94.87 $237,175 D/D (2,500) 853 21%     
   Hastings Paul J Director   –       •      –    2014-10-10 4 OE $13.98 $34,950 D/D 2,500 3,353     -
   Longenecker John P Phd Director   –       •      –    2014-09-29 4 OE $29.90 $29,900 D/D 1,000 1,000     -
   Longenecker John P Phd Director   –       •      –    2014-09-29 4 AS $96.40 $96,400 D/D (1,000) 0 17%     
   Wicki Andreas Director   –       •      –    2014-08-29 4 S $108.15 $1,133,560 I/I (10,481) 1,100,100 -7%     
   Wicki Andreas Director   –       •      –    2014-08-28 4 S $108.06 $1,190,097 I/I (11,013) 1,110,581 -8%     
   Wicki Andreas Director   –       •      –    2014-08-27 4 S $108.05 $173,535 I/I (1,606) 1,121,594 -8%     
   Wicki Andreas Director   –       •      –    2014-08-26 4 S $108.11 $2,617,016 I/I (24,207) 1,123,200 -8%     
   Wicki Andreas Director   –       •      –    2014-08-25 4 S $108.07 $3,241,983 I/I (30,000) 1,147,407 -8%     
   Wicki Andreas Director   –       •      –    2014-08-11 4 S $101.20 $6,894,905 I/I (67,900) 1,177,407 -8%     

  266 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed